On 12th November 1993, Bruno C. Wassmer – a pharmaceutical specialist from Freiburg - , Gernot Harrant – a chemist from Salzburg – and Lutz Mothes – a pharmacist from Frankfurt – founded Inresa Arzneimittel GmbH after 30 years in the pharmaceutical industry and the sale of CuraMED Pharma GmbH.
In the following 4 years, dossiers were written to obtain market authorizations, scientific studies were carried out and its own research projects were developed. In 1997, Inresa’s first pharmaceutical products were approved by the BfArM (Federal Institute for Drugs and Medical Devices) in Bonn.
1997 - Entry into the market
In 1997, Inresa launched three pharmaceutical products. At that time, Henric Wassmer, the son of Bruno Wassmer, became responsible for the clinical field service in the whole of Germany and the specialized, family-run business steadily became established in the complex German hospital market.
Due to the constant growth in sales, the number of employees and marketing authorizations increased.
2003 - New premises
Soon, there was not enough space for the new employees and the multitude of stored pharmaceutical products. In 2003, the owners acquired a commercial property with a storage area for pharmaceutical products.
Today, Inresas’ pharmaceutical products are delivered from here to hospitals, to in-house pharmacies and to wholesalers as well as to public pharmacies. In adition, products are exported worldwide two or three times a day.
2006 - Generation change
After 13 years at Inresa and 40 years in the pharmaceutical industry, Bruno C. Wassmer passed on the commercial management of the Inresa Arzneimittel GmbH to his son Henric Wassmer.
However, the three founders still act as consultants and therefore their expertise remains in the company.
2010 - Entry into the international market
In 2010, Inresa ventured into international markets. This step was achieved by the partnership with Flynn Pharma Ltd. Flynn Pharma Ltd. is a fast growing pharmaceutical company located in Old Stevenage, Hertfordshire. It has operated with great success on the British and Irish pharmaceutical markets since 2004.
The group of companies – with Flynn Pharma Ltd. in the United Kingdom, Inresa Arzneimittel GmbH and Inresa GmbH & co. KG in Germany and Inresa France in France – operates in the three largest European markets and is able to serve them from a single source. Each of the companies has a similar company size, quick decision-making, good interaction and modern structures which are the driving forces behind the achievement of this goal.